# AstraZeneca (United Kingdom)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/astrazeneca-united-kingdom/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 61.6 |
| Citations | 2,781,306 |
| City | Cambridge |
| Country | GB |
| Description | AstraZeneca (United Kingdom) is a research organisation in Cambridge, GB. OpenAlex records 21,210 works and 2,781,306 citations for it. 5,209 researchers list it as their most recent affiliation. |
| Homepage | https://www.astrazeneca.com |
| OpenAlex ID | https://openalex.org/I105036370 |
| Region | England |
| Researchers | 5,209 |
| ROR ID | https://ror.org/04r9x1a08 |
| Type | company |
| Works | 21,210 |

## University papers

Showing 12 of 108.

- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)
- [Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-untreated-i-egfr-i-mutated-advanced-non-small-cell-lung-cancer/)
- [Genetic studies of body mass index yield new insights for obesity biology](https://scholariq.org/papers/genetic-studies-of-body-mass-index-yield-new-insights-for-obesity-biology/)
- [Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction](https://scholariq.org/papers/eplerenone-a-selective-aldosterone-blocker-in-patients-with-left-ventricular/)
- [FinnGen provides genetic insights from a well-phenotyped isolated population](https://scholariq.org/papers/finngen-provides-genetic-insights-from-a-well-phenotyped-isolated-population/)
- [An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics](https://scholariq.org/papers/an-integrated-tcga-pan-cancer-clinical-data-resource-to-drive-high-quality/)
- [The repertoire of mutational signatures in human cancer](https://scholariq.org/papers/the-repertoire-of-mutational-signatures-in-human-cancer/)
- [Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers](https://scholariq.org/papers/inhibition-of-poly-adp-ribose-polymerase-in-tumors-from-i-brca-i-mutation/)
- [Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients](https://scholariq.org/papers/mutational-landscape-of-metastatic-cancer-revealed-from-prospective-clinical/)
- [Oncogenic Signaling Pathways in The Cancer Genome Atlas](https://scholariq.org/papers/oncogenic-signaling-pathways-in-the-cancer-genome-atlas/)
- [Pan-cancer analysis of whole genomes](https://scholariq.org/papers/pan-cancer-analysis-of-whole-genomes/)

## University researchers

- [Willem J. Remme](https://scholariq.org/researchers/willem-j-remme/)
- [Graham Fraser](https://scholariq.org/researchers/graham-fraser/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.